Stocktoria
Personalis, Inc. PSNL
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2019-06-20
Personalis, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -126.4% | -80.7% | -149.6% | -177.6% | -76.4% |
| Net margin | -116.7% | -96.1% | -147.4% | -174.2% | -76.3% |
| FCF margin | -114.1% | -55.3% | -91.4% | -184.7% | -95.8% |
| Return on assets | -24.3% | -30.1% | -48.1% | -38.7% | -16.4% |
| Return on equity | -31.1% | -40.0% | -83.7% | -51.9% | -21.0% |
| Current ratio | 6.76 | 6.52 | 3.11 | 6.03 | 10.16 |
| Revenue growth | -17.7% | 15.2% | 13.0% | -23.9% | 8.7% |
Source: SEC EDGAR filings · CIK 0001527753 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.